Robert Kniaz
QuietNamed in filings at Hoxton Ventures
- Board seats filed
- 8
all filings on record
Named in filings at Hoxton Ventures
all filings on record
last 24 months
from a verified or cited source
| PharmaCCX | Enterprise software | June 2023 | None on file |
| Phagos | Biotech & pharma | July 2022 | None on file |
| Aviceda Ophthalmics | Biotech & pharma | March 2022 | None on file |
| Assetario | AI & machine learning | March 2022 | None on file |
| OUROTECH, INC.- PEAR BIO | Biotech & pharma | October 2021 | None on file |
| FabricNano | Biotech & pharma | May 2021 | None on file |
| Preply | Education | March 2021 | None on file |
| Spacelift | Developer tools & infrastructure | December 2020 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Robert Kniaz on the board, based on 8 filed seats with a verified or cited source.